Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
33
Top-10 weight
51.04%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
25
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
669.8
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | ARGENX SE SPONSORED ADR | — | 235 | $171.61K | 8.03% |
| 2 | LILLY ELI and CO | — | 181 | $166.48K | 7.79% |
| 3 | Ascendis Pharma A/S | — | 512 | $117.11K | 5.48% |
| 4 | NEKTAR THERAPEUTICS | — | 1,412 | $101.59K | 4.75% |
| 5 | THERMO FISHER SCIENTIFIC INC | — | 186 | $91.42K | 4.28% |
| 6 | ALIGN TECHNOLOGY INC | — | 521 | $89.32K | 4.18% |
| 7 | ENLIVEN THERAPEUTICS INC | — | 2,126 | $83.34K | 3.90% |
| 8 | 10X GENOMICS INC | — | 3,801 | $80.70K | 3.77% |
| 9 | NEWAMSTERDAM PHARMA COMPANY NV | — | 2,383 | $76.28K | 3.57% |
| 10 | STRUCTURE THERAPEUTICS INC ADR | — | 1,489 | $71.77K | 3.36% |
| 11 | CERIBELL INC | — | 3,915 | $71.76K | 3.36% |
| 12 | DOXIMITY INC-A | — | 2,688 | $62.63K | 2.93% |
| 13 | INTUITIVE SURGICAL INC | — | 132 | $60.85K | 2.85% |
| 14 | GUARDANT HEALTH INC | — | 631 | $58.29K | 2.73% |
| 15 | ALNYLAM PHARMACEUTICALS INC | — | 175 | $57.90K | 2.71% |
| 16 | VERTEX PHARMACEUTICALS INC | — | 128 | $57.16K | 2.67% |
| 17 | VAXCYTE INC | — | 952 | $55.32K | 2.59% |
| 18 | ILLUMINA INC | — | 437 | $53.86K | 2.52% |
| 19 | INSPIRE MEDICAL SYSTEMS INC | — | 1,030 | $53.13K | 2.48% |
| 20 | ZOETIS INC CL A | — | 411 | $48.58K | 2.27% |
| 21 | UNITEDHEALTH GRP | — | 172 | $46.54K | 2.18% |
| 22 | KYMERA THERAPEUTICS INC | — | 534 | $44.48K | 2.08% |
| 23 | DEXCOM INC | — | 677 | $42.52K | 1.99% |
| 24 | BEAM THERAPEUTICS INC | — | 1,602 | $38.18K | 1.79% |
| 25 | WEST PHARMACEUTICAL SVCS INC | — | 146 | $36.59K | 1.71% |
| 26 | ATAIBECKLEY INC | — | 9,857 | $34.89K | 1.63% |
| 27 | MAXCYTE INC | — | 49,461 | $34.75K | 1.63% |
| 28 | VEEVA SYSTEMS-A | — | 190 | $33.38K | 1.56% |
| 29 | MSILF-TR SEC-INS | MSUXX | 32,707 | $32.71K | 1.53% |
| 30 | SCHRODINGER INC | — | 2,552 | $28.99K | 1.36% |
| 31 | TEMPUS AI INC-A | — | 577 | $26.09K | 1.22% |
| 32 | ULTRAGENYX PHARMA INC | — | 758 | $15.88K | 0.74% |
| 33 | UNIQURE N.V. | — | 746 | $12.20K | 0.57% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.